---
title: "Lixte Biotechnology Completes Merger With NOMAD; Issues 50.4K Series D Preferred and 3.0M Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291584133.md"
description: "Lixte Biotechnology completed its merger with NOMAD Transportable Power Systems, issuing approximately 50.4K Series D Preferred and 3.0M common shares. Concurrently, Lixte signed a Registration Rights Agreement to facilitate resale of these shares and secured Stockholder Support Agreements to ensure approval for post-merger actions, including preferred conversion and board elections."
datetime: "2026-07-02T20:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291584133.md)
  - [en](https://longbridge.com/en/news/291584133.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291584133.md)
generator: "portal-rs"
---

# Lixte Biotechnology Completes Merger With NOMAD; Issues 50.4K Series D Preferred and 3.0M Shares

Lixte Biotechnology closed its acquisition of NOMAD Transportable Power Systems via merger, issuing 50,366.07 shares of Series D Convertible Preferred (convertible at $1.00) and 2,992,041 common shares at closing, with capacity for up to 50,500 preferred and roughly 3,000,005 common in total. An amendment updated fractional-share handling and the consideration schedule. Concurrently, Lixte signed a Registration Rights Agreement to register resales of the issued shares under specified timelines and secured Stockholder Support Agreements to back key post-merger approvals, including preferred conversion and board elections.

**Agreement 1: Lixte Biotechnology Completes Merger With NOMAD; Issues 50.4K Series D Preferred and 3.0M Shares**

-   **Agreement type**: Merger Agreement and Amendment No. 1
-   **Counterparty**: NOMAD Transportable Power Systems
-   **Signed / Effective**: Jun 11 2026 / Jul 01 2026
-   **Duration / Termination**: Until closing
-   **Reason**: Transform business via acquisition of mobile power platform

**Agreement 2: Lixte Grants Resale Rights to NOMAD Holders With Post-Approval Registration Timeline**

-   **Agreement type**: Registration Rights Agreement
-   **Counterparty**: Holders of NOMAD common stock
-   **Signed / Effective**: Jul 01 2026 / Jul 01 2026
-   **Duration / Termination**: Until resale registration completed
-   **Reason**: Provide liquidity to former NOMAD holders

**Agreement 3: Lixte Secures Stockholder Support Commitments for Post-Merger Approvals**

-   **Agreement type**: Stockholder Support Agreement
-   **Counterparty**: Supporting Stockholders of Lixte
-   **Signed / Effective**: Jul 01 2026 / Jul 01 2026
-   **Duration / Termination**: Until stockholder vote
-   **Reason**: Secure votes for conversion and governance approvals

Original SEC Filing: LIXTE BIOTECHNOLOGY HOLDINGS, INC. \[ LIXT \] - 8-K - Jul. 02, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [LIXT.US](https://longbridge.com/en/quote/LIXT.US.md)

## Related News & Research

- [REG - Leverage Shares PLC Leverage 3X DIS $ Leverage 3X DIS £ Leverage 3X DIS E - Consolidation Notice-3x Disney ETP](https://longbridge.com/en/news/298330618.md)
- [$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Proxy and Looming Shareholder Merger Vote --VRME, VAL, LAB and FTHM](https://longbridge.com/en/news/298634853.md)
- [Alpha Star Acquisition Corp announces extraordinary shareholder meeting](https://longbridge.com/en/news/298632178.md)
- [VEEE: Stockholders approved a 1-for-37 reverse split and a company name change; results to be filed soon](https://longbridge.com/en/news/298335328.md)
- [MariMed announces special shareholder meeting](https://longbridge.com/en/news/298764999.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**